INTERNATIONAL PATENT: ALMIRALL, S.A. FILES APPLICATION FOR "INJECTABLE FORMULATIONS COMPRISING TIRBANIBULIN"

GENEVA, Feb. 2 -- ALMIRALL, S.A. (Ronda del General Mitre 15108022 Barcelona) filed a patent application (PCT/EP2025/071168) for "INJECTABLE FORMULATIONS COMPRISING TIRBANIBULIN" on Jul 23, 2025. With publication no. WO/2026/022219, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): OTERO RODRIGUEZ, Raquel (c/ Laurea Miro, 408-410,08980 Sant Feliu de Llobregat)

Abstract: The disclosure provides an injectable pharmaceutical formulation comprising tirbanibulin, in free or pharmaceutically acceptable salt form, for local injec...